GM vs VRTX · P/E 7.5, rev $185.02B vs P/E 30, rev $12.00B
General Motors Company (GM) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
General Motors Company (GM) is a auto manufacturers company listed on US. It is led by Mary Barra.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported GM revenue for 2025-12-31 was $185.02B. Net income was $2.70B. Revenue was down 1.3% from 2024-12-31 to 2025-12-31. GM currently screens at market cap $51.33B and trailing P/E 7.5.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
GM currently screens at market cap $51.33B and trailing P/E 7.5. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the GM and VRTX stock pages for the full models.
Not investment advice.